Adedeji Adebayo, Nnaji Ikechukwu, Muhammad Fahad, Amaza Rahab, Adewusi Adetunji, Ojo Johnson, Ojenya Enoch, Mustapha Abdulrahman, Gassi Solomon, Klink Patrycja, Bock C Thomas, Ihekweazu Chikwe, Idris Jide, Harms Dominik
Nigeria Centre for Disease Control and Prevention (NCDC), Abuja, Nigeria.
State Ministry of Health, Borno, Nigeria.
IJID Reg. 2024 Oct 24;13:100481. doi: 10.1016/j.ijregi.2024.100481. eCollection 2024 Dec.
Following the outbreak of hepatitis E in camps for internally displaced persons (IDPs) in Borno State in 2017, we assessed hepatitis B, C, and E biomarkers (hepatitis B surface antigen [HBsAg], anti-HBC, anti-hepatitis E virus [HEV] immunoglobulin [Ig] G, and anti-HEV IgM) among IDPs in three camps in Borno State, Nigeria, to determine seroprevalence rates in these understudied populations.
A total of 454 IDPs, including pregnant women and breastfeeding mothers, were randomly selected, and their demographic, clinical, and epidemiological data were collected. Blood samples were tested for HBsAg and anti-hepatitis C virus (HCV) using rapid tests, anti-HEV IgM, and anti-HEV IgG using enzyme-linked immunosorbent assay.
The seroprevalences were 13.7% for HBsAg, 1.3% for anti-HCV, 41.9% for anti-HEV IgG, and 0% for anti-HEV IgM. There were differences between the camps depending on the displaced community. Common detection occurred in 0.2% for HBsAg/anti-HCV, 4.2% for HBsAg/anti-HEV IgG, and 0.7% for anti-HCV/anti-HEV IgG. In pregnant women, HBsAg/anti-HEV IgG co-detection rate was 28.6%, whereas HBsAg and anti-HEV IgG rates alone were 13.4% and 32.8%, respectively. Among breastfeeding mothers, 17.1%, 2.4%, and 36.6% were positive for HBsAg, anti-HCV, and anti-HEV IgG, respectively, whereas 2.2% of them were positive for both HBsAg and anti-HEV IgG.
The prevalence of viral hepatitis biomarkers among the IDPs studied was higher than those reported in national figures and differed according to camps and population subgroups. There is a need for improved surveillance and access to testing for viral hepatitis biomarkers for the purpose of improved disease prevention and control in these medically underserved populations.
2017年博尔诺州境内流离失所者(IDP)营地爆发戊型肝炎疫情后,我们评估了尼日利亚博尔诺州三个营地的IDP中的乙型、丙型和戊型肝炎生物标志物(乙型肝炎表面抗原[HBsAg]、抗-HBC、抗戊型肝炎病毒[HEV]免疫球蛋白[Ig]G和抗-HEV IgM),以确定这些研究较少人群中的血清流行率。
共随机选取454名IDP,包括孕妇和哺乳期母亲,收集其人口统计学、临床和流行病学数据。使用快速检测法检测血样中的HBsAg和抗丙型肝炎病毒(HCV),使用酶联免疫吸附测定法检测抗-HEV IgM和抗-HEV IgG。
HBsAg的血清流行率为13.7%,抗-HCV为1.3%,抗-HEV IgG为41.9%,抗-HEV IgM为0%。不同营地之间存在差异,具体取决于流离失所社区。HBsAg/抗-HCV的共同检出率为0.2%,HBsAg/抗-HEV IgG为4.2%,抗-HCV/抗-HEV IgG为0.7%。在孕妇中,HBsAg/抗-HEV IgG的共同检出率为28.6%,而单独的HBsAg和抗-HEV IgG率分别为13.4%和32.8%。在哺乳期母亲中,HBsAg、抗-HCV和抗-HEV IgG的阳性率分别为17.1%、2.4%和36.6%,而其中2.2%的母亲HBsAg和抗-HEV IgG均为阳性。
在所研究的IDP中,病毒性肝炎生物标志物的流行率高于国家报告中的数据,并且因营地和人群亚组而异。为了在这些医疗服务不足的人群中改善疾病预防和控制,需要加强监测并增加获得病毒性肝炎生物标志物检测的机会。